COVID Treatment Shows Encouraging Results in Trial, Study Says
A single-injection antiviral treatment for newly infected COVID-19 patients reduced the risk of hospitalization by half in a large-scale clinical trial, a study published Wednesday said. Stanford University professor Jeffrey Glenn, co-author of the study published in the New England Journal of Medicine, said the new drug “showed profound benefits for vaccinated and unvaccinated people alike.” While the number of Americans dying daily of the disease caused by a coronavirus has fallen to about 500, treatments for COVID-19 remain limited. One of the most common — Paxlovid, made by Pfizer …